FDA Approves New Drug For Severe Multiple Sclerosis

“This sort of opens the door for us,” Dr. Fred Lublin, an investigator for the clinical trials and director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Hospital, told The New York Times. “Once we open that door, then we do better and better and better. It’s a very encouraging result.”